Alterations in polyadenylation and its implications for endocrine disease

Area of Science:

• Molecular Biology
• Genetics
• Endocrinology

Background:

• Polyadenylation is crucial for mRNA formation, with alternative polyadenylation (APA) generating diverse mRNA isoforms.
• APA affects gene expression and post-transcriptional regulation via 3' untranslated regions (3' UTRs).
• Two-thirds of human genes utilize APA, highlighting its widespread regulatory role.

Purpose of the Study:

• To review alterations in polyadenylation associated with endocrine diseases.
• To summarize current literature on polyadenylation and its clinical implications.
• To explore the potential of new therapeutic approaches targeting polyadenylation.

Main Methods:

• Review of current literature on polyadenylation and endocrine diseases.
• Discussion of recent advancements in genome-wide polyadenylation characterization.
• Exploration of therapeutic strategies involving antisense elements.

Main Results:

• Alterations in polyadenylation are implicated in neonatal diabetes, IPEX, types I and II diabetes, pre-eclampsia, and endocrine-related cancers.
• APA influences gene expression and disease pathogenesis through regulatory elements in 3' UTRs.
• High-throughput sequencing enables comprehensive genome-wide polyadenylation analysis.

Conclusions:

• APA plays a significant role in endocrine disease development and progression.
• Targeting polyadenylation processes with antisense elements shows therapeutic promise.
• Further research is needed to fully understand and leverage polyadenylation in disease management.